About Us
- Meet Our Team
  The Wisconsin Child Psychiatry Consultation Program (WI CPCP) is comprised of a multidisciplinary team of clinicians, administrators, and staff.
- Frequently Asked Questions
  Learn more about our program and see answers to common questions from those who engage with our services.
Consultations
Resources
- Newsletters and Case Studies
  The WI CPCP publishes quarterly e-newsletters featuring medication facts, curated articles, links to resources, and in-depth case studies.
- Screening Tools and Rating Scales
  The screening tools, rating scales, practice parameters, and medication reference materials can help primary care providers identify and manage pediatric patients’ mild to moderate mental health concerns.
Education and CME
- Online CME
  Our education modules developed by child psychiatrists and pediatric psychologists help primary care practitioners learn more about managing pediatric mental health issues.
- Live Provider Education
  The Wisconsin CPCP can present live education on mental and behavioral health topics specifically designed for primary care providers.
- Clinic Staff Education
  WI CPCP's Clinic Staff Educational content is designed for nurses, medical assistants, and other clinic support staff in the primary care setting, and contains online learning modules.
- Conference
  Learn about our conferences where regional and national experts provide education on pediatric mental health topics.
Join

WICPCP Consultations_Hero

WI CPCP Resources

The WI CPCP regularly updates resources for families and providers.

Wisconsin CPCP /
Resources /
Newsletters and Case Studies

WI CPCP Newsletters & Case Studies

The WI CPCP publishes quarterly e-newsletters featuring medication facts, curated articles, links to resources, and in-depth case studies.

This information is for professionals who provide mental health services. The material is intended as general information and not as a recommendation for specific treatment. The content may not be re-used, modified, or distributed without prior written permission.

Read WI CPCP's Latest Newsletter

May 2026: ADHD and Substance Misuse

ADHD CUD - May '26 Newsletter Image

Practical guidance for PCPs navigating stimulant prescribing and substance misuse-related health risks in youth.

Read all of the May 2026 newsletter

Past Newsletters and Consultation Case Studies

all

2026

February 2026
Disruptive Behavior, Emotional Dysregulation, and PCIT

2025

November 2025
Peer Suicide and Sextortion: Rapid Response for Adolescent Safety

August 2025
School Avoidance and Absenteeism: The Role of PCPs in Promoting Positive School Experiences

May 2025
The Role of PCPs in Promoting Mental Wellness

April 2025
Autism Spectrum Disorder (ASD)

March 2025
Intellectual Developmental Disorder (IDD)

February 2025
Supporting Pediatric Patients with OCD

January 2025
Mental Health and School Systems

2024

November 2024
Sleep Hygiene and Electronic Devices

October 2024
Trauma-Related Distress

September 2024
Youth Suicide Prevention in Pediatric Care

August 2024
ADHD and Back to School

Consultation Case Studies

Specific Symptoms or Diagnosis

ADHD

ADHD and Back to School (PDF)
ADHD and Substance Misuse (PDF)

Eating Disorders

Eating Disorders Case Study (PDF)

Suicidality and Non-Suicidal Self Injurious Behavior

Mental Health at School

Back to School-IEP-504-ASQ (PDF)
Individual Education Plan (IEP) (PDF)
Mental Health and the School System (PDF)
School Avoidance and Absenteeism (PDF)

Other Topics

Autism Spectrum Disorder (ASD) (PDF)
Building Healthier Future: The Role of PCPs in Promoting Mental Wellness (PDF)
Intellectual Developmental Disorder (IDD) (PDF)
Managing Disruptive Behaviors (PDF)
Minority Mental Health (PDF)
Social Media (PDF)

Medication Information Sheets

Psychiatric medication fact sheets provide information about mechanisms of action, selection, dosage, and side effects of medications commonly used in the pediatric population.

Stimulants

Amphetamine Sulfate (Evekeo) (PDF)
Daytrana (PDF)
Dexmethylphenidate (Focalin XR) (PDF)
JORNAY PM (PDF)
Lisdexamfetamine (Vyvanse) (PDF)
Methylphenidate HCL (Apstensio XR) (PDF)

Antidepressants

Antipsychotics

Sleep Agents

Melatonin (PDF)

Non-stimulant ADHD Medication

Atomoxetine (Strattera) (PDF)
Qelbree (Viloxazine) (PDF)